Image source: © 2025 Krish Capital Pty. Ltd.
Highlights
-
IRE's 1H25 underlying EPS from continuing business increased 19% compared to the prior corresponding period.
-
Proceeds from divestments, including the Superannuation business, reduced leverage ratio to 0.8x.
-
FY25 Adjusted EBITDA guidance maintained at AUD 127–135 million, with UPAT forecast at AUD 65–73 million.
Iress Limited (ASX:IRE) has announced its financial results for the six months ended 30 June 2025, delivering statutory net profit after tax (NPAT) of AUD 17.3 million, unchanged from the prior year. Reported revenue was AUD 299.5 million, down 3.1% from 1H24, reflecting the impact of divestments completed during the period, including the sale of the Superannuation business in May 2025.
On a continuing business basis, which excludes contributions from divested assets, revenue increased 6.8%, driven by growth in the UK operations and performance from the Global Trading & Market Data business. APAC Wealth revenue declined slightly due to a client business restructure in mid-2024.
Earnings and Costs
Adjusted EBITDA for the half was AUD 64.4 million, 3.9% lower than 1H24. Excluding divested businesses, continuing business Adjusted EBITDA was AUD 60.2 million, an increase of AUD 4.8 million or 8.7% year-on-year, supported by pricing improvements, productivity gains, and efficiency measures.
Operating costs were AUD 235.1 million, 2.9% lower than the prior corresponding period due to reduced headcount and tighter management of non-wage expenses. On a continuing business basis, costs increased 6.2%, reflecting higher research and development investment in next-generation wealth technologies for the unadvised market.
Transformation and Balance Sheet
Iress completed its transformation program during the half, with asset sales aimed at streamlining the business and focusing on core operations. In addition to the Superannuation business divestment, the company entered into a binding agreement to sell QuantHouse, with completion expected in the third quarter of 2025.
Proceeds from the Superannuation sale were applied to debt repayment, reducing the company’s leverage ratio to 0.8x, down significantly from the prior year.
Dividend
The Board declared an interim dividend of 11.0 cents per share, 50% franked, representing a payout ratio of 62% for the half year. The dividend will be paid on 22 September 2025 to shareholders on record as at 25 August 2025.
Outlook
Iress reaffirmed its FY25 guidance, with Adjusted EBITDA forecast in the range of AUD 127 million to AUD 135 million and underlying profit after tax (UPAT) between AUD 65 million and AUD 73 million. The company stated that growth in its core businesses is expected to offset the loss of contribution from divested businesses and increased investment in research and development.
For the remainder of FY25, Iress plans to continue strategic investment in its core offerings, develop complementary new products, and expand partnerships in data and AI to capture additional revenue streams. The company also intends to maintain its focus on initiatives aimed at enhancing customer experience.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.